NYSE: EHC · Industrial Applications and Services · 4 alerts · CIK 785161
Share price
$142.11Close, Nov 16
Market cap
$13.9B
Shares outstanding
98.12MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Services-HospitalsSIC 8060
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Encompass Health Corp filings on SEC EDGAR ↗
Encompass Health announced the indefinite closure of its 90-bed Sea Pines Rehabilitation Hospital in Melbourne, Florida, following catastrophic flooding and patient evacuation on November 1-2, 2026. The company is evaluating options to refurbish or replace the facility with its joint venture partner, Holmes Regional Medical Center. Despite the closure, the company reaffirmed its full-year 2026 financial guidance.
Encompass Health reported net operating revenues of $1,609.5 million for the third quarter of 2026, a 9% increase over the prior year. Net income attributable to the company rose to $149.9 million, driven by strong performance in continuing operations despite increased operating expenses and share repurchases totaling $204.2 million for the nine-month period.
Encompass Health delivered a strong Q3 2026 beat and raised full-year guidance, driven by high-acuity patient mix and effective labor cost management despite regulatory headwinds.
Encompass Health reported Q3 2026 net operating revenue of $1.61 billion, an 8.9% increase year-over-year, driven by a 5.7% growth in discharges. The company increased its full-year 2026 guidance for revenue, Adjusted EBITDA, and adjusted EPS following strong performance and the opening of four new hospitals year-to-date.
Term
Q3 2026
“We are very pleased with our performance for the third quarter, with revenue increasing 8.9% and Adjusted EBITDA growing 15.5%. During the first nine months of 2026, we opened four hospitals totaling 189 beds and added 85 beds to existing hospitals, reflecting our commitment to meeting the growing demand for high-quality inpatient rehabilitation services. Our value proposition and disciplined operating strategy continue to be validated, and we remain highly optimistic about the long-term prospects of our business.”